Trond Warloe
- MD; PhD
- +47 22 93 55 93
Publications 2024
Extracorporeal Photopheresis with 5-Aminolevulinic Acid in Crohn's Disease-A First-in-Human Phase I/II Study
J Clin Med, 13 (20)
DOI 10.3390/jcm13206198, PubMed 39458148
Publications 2023
Photodynamic Effects with 5-Aminolevulinic Acid on Cytokines and Exosomes in Human Peripheral Blood Mononuclear Cells from Patients with Crohn's Disease
Int J Mol Sci, 24 (5)
DOI 10.3390/ijms24054554, PubMed 36901982
Publications 2022
Amphiphilic Protoporphyrin IX Derivatives as New Photosensitizing Agents for the Improvement of Photodynamic Therapy
Biomedicines, 10 (2)
DOI 10.3390/biomedicines10020423, PubMed 35203632
Photodynamic Effects with 5-Aminolevulinic Acid on Cytokines and Exosomes in Human Peripheral Blood Mononuclear Cells
Biomedicines, 10 (2)
DOI 10.3390/biomedicines10020232, PubMed 35203441
Publications 2017
Improved treatment decisions in patients with esophageal cancer
Acta Oncol, 56 (10), 1286-1294
DOI 10.1080/0284186X.2017.1346379, PubMed 28686501
Publications 2015
Randomised controlled trial of temoporfin photodynamic therapy plus chemotherapy in nonresectable biliary carcinoma--PCS Nordic study
Photodiagnosis Photodyn Ther, 13, 330-333
DOI 10.1016/j.pdpdt.2015.09.004, PubMed 26415549
Vulvovaginal photodynamic therapy vs. topical corticosteroids in genital erosive lichen planus: a randomized controlled trial
Br J Dermatol, 173 (5), 1156-62
DOI 10.1111/bjd.14033, PubMed 26189484
Publications 2014
Modification of extracorporeal photopheresis technology with porphyrin precursors. Comparison between 8-methoxypsoralen and hexaminolevulinate in killing human T-cell lymphoma cell lines in vitro
Biochim Biophys Acta, 1840 (9), 2702-8
DOI 10.1016/j.bbagen.2014.05.020, PubMed 24915603
Biodistribution of protoporphyrin IX in female genital erosive lichen planus after topical application of hexaminolevulinate
Photodiagnosis Photodyn Ther, 11 (2), 113-7
DOI 10.1016/j.pdpdt.2014.01.005, PubMed 24530993
Reply to comments of the article "photodynamic treatment of oral lichen planus"
Oral Surg Oral Med Oral Pathol Oral Radiol, 117 (2), 257-8
DOI 10.1016/j.oooo.2013.08.013, PubMed 24439922
Publications 2013
Palliative brachytherapy with or without primary stent placement in patients with oesophageal cancer, a randomised phase III trial
Radiother Oncol, 107 (3), 428-33
DOI 10.1016/j.radonc.2013.04.008, PubMed 23647761
Photodynamic treatment of oral lichen planus
Oral Surg Oral Med Oral Pathol Oral Radiol, 115 (1), 62-70
DOI 10.1016/j.oooo.2012.08.448, PubMed 23217536
Publications 2011
Palliative interventions and prognosis in patients with advanced esophageal cancer
Dis Esophagus, 24 (7), 502-9
DOI 10.1111/j.1442-2050.2010.01174.x, PubMed 21309923
Publications 2010
Radical treatment for oesophageal cancer patients unfit for surgery and chemotherapy. A 10-year experience from the Norwegian Radium Hospital
Acta Oncol, 49 (2), 209-18
DOI 10.3109/02841860903246573, PubMed 19929566
Publications 2009
Short incubation with methyl aminolevulinate for photodynamic therapy of actinic keratoses
J Eur Acad Dermatol Venereol, 23 (5), 550-5
DOI 10.1111/j.1468-3083.2008.03029.x, PubMed 19415804
Guidelines for practical use of MAL-PDT in non-melanoma skin cancer
J Eur Acad Dermatol Venereol, 24 (5), 505-12
DOI 10.1111/j.1468-3083.2009.03430.x, PubMed 19807828
Adenocarcinomas on the rise--does it influence survival from oesophageal cancer?
Scand J Surg, 98 (4), 214-20
DOI 10.1177/145749690909800404, PubMed 20218417
Publications 2008
Photodynamic therapy with 5-aminolaevulinic acid, dimethylsulfoxide and curettage in basal cell carcinoma: a 6-year clinical and histological follow-up
J Eur Acad Dermatol Venereol, 23 (1), 58-66
DOI 10.1111/j.1468-3083.2008.02946.x, PubMed 18803580
Lasers in medicine
Rep. Prog. Phys., 71 (5), 056701
DOI 10.1088/0034-4885/71/5/056701
Publications 2007
Phototoxic reaction and porphyrin fluorescence in skin after topical application of methyl aminolaevulinate
Br J Dermatol, 156 (2), 301-7
DOI 10.1111/j.1365-2133.2006.07638.x, PubMed 17223870
Photodynamic therapy with methyl aminolevulinate for atypial carcinoma in situ of the penis
Scand J Urol Nephrol, 41 (6), 507-10
DOI 10.1080/00365590701428590, PubMed 17853049
Clinical evaluation of bioadhesive hydrogels for topical delivery of hexylaminolevulinate to Barrett's esophagus
J Control Release, 123 (3), 203-10
DOI 10.1016/j.jconrel.2007.08.015, PubMed 17884228
Detection of urinary bladder cancer with flow cytometry and hexaminolevulinate in urine samples
Cytopathology, 18 (2), 87-95
DOI 10.1111/j.1365-2303.2007.00436.x, PubMed 17397493
Photodynamic treatment of oral lesions
J Environ Pathol Toxicol Oncol, 26 (2), 127-33
DOI 10.1615/jenvironpatholtoxicoloncol.v26.i2.70, PubMed 17725538
Publications 2006
Porphyrin formation in actinic keratosis and basal cell carcinoma after topical application of methyl 5-aminolevulinate
J Invest Dermatol, 126 (2), 265-71
DOI 10.1038/sj.jid.5700048, PubMed 16374471
Quality of life after total or partial gastrectomy for primary gastric lymphoma
Acta Oncol, 45 (2), 202-9
DOI 10.1080/02841860500492067, PubMed 16546867
[Retraction of: Diagnostics and treatment of early stages of oral cancer]
Tidsskr Nor Laegeforen, 126 (17), 2287
PubMed 16967079
Publications 2005
Porphyrin-related photosensitizers for cancer imaging and therapeutic applications
J Microsc, 218 (Pt 2), 133-47
DOI 10.1111/j.1365-2818.2005.01471.x, PubMed 15857375
Publications 2003
Topical methyl aminolaevulinate photodynamic therapy in patients with basal cell carcinoma prone to complications and poor cosmetic outcome with conventional treatment
Br J Dermatol, 149 (6), 1242-9
DOI 10.1111/j.1365-2133.2003.05600.x, PubMed 14674903
Publications 2002
Cytologic screening for esophageal cancer in a high-risk population in Anyang County, China
Acta Cytol, 46 (3), 445-52
DOI 10.1159/000326859, PubMed 12040635
Publications 2001
Selective distribution of porphyrins in skin thick basal cell carcinoma after topical application of methyl 5-aminolevulinate
J Photochem Photobiol B, 62 (3), 140-5
DOI 10.1016/s1011-1344(01)00173-7, PubMed 11566277
Antitumor effect of 5-aminolevulinic acid-mediated photodynamic therapy can be enhanced by the use of a low dose of photofrin in human tumor xenografts
Cancer Res, 61 (15), 5824-32
PubMed 11479222
A follow-up study of recurrence and cosmesis in completely responding superficial and nodular basal cell carcinomas treated with methyl 5-aminolaevulinate-based photodynamic therapy alone and with prior curettage
Br J Dermatol, 145 (3), 467-71
DOI 10.1046/j.1365-2133.2001.04407.x, PubMed 11531838
[Diagnosis and treatment of oral precancerous lesions]
Tidsskr Nor Laegeforen, 121 (26), 3066-71 (Retracted)
PubMed 11757442
Publications 2000
Photodynamic therapy of superficial basal cell carcinoma with 5-aminolevulinic acid with dimethylsulfoxide and ethylendiaminetetraacetic acid: a comparison of two light sources
Photochem Photobiol, 71 (6), 724-9
DOI 10.1562/0031-8655(2000)071<0724:ptosbc>2.0.co;2, PubMed 10857368
Photodynamic therapy of residual or recurrent basal cell carcinoma after radiotherapy using topical 5-aminolevulinic acid or methylester aminolevulinic acid
Acta Oncol, 39 (5), 605-9
DOI 10.1080/028418600750013285, PubMed 11093368
Publications 1999
Skin scrape cytology in the diagnosis of nodular basal cell carcinoma for treatment by photodynamic therapy
Acta Derm Venereol, 79 (2), 147-9
DOI 10.1080/000155599750011408, PubMed 10228637
Photodynamic therapy by topical aminolevulinic acid, dimethylsulphoxide and curettage in nodular basal cell carcinoma: a one-year follow-up study
Acta Derm Venereol, 79 (3), 204-6
DOI 10.1080/000155599750010977, PubMed 10384917
Publications 1998
Nonrandom numerical chromosome abnormalities in basal cell carcinomas
Cancer Genet Cytogenet, 103 (1), 35-42
DOI 10.1016/s0165-4608(97)00356-7, PubMed 9595042
Publications 1997
The reciprocal translocation t(9;16)(q22;p13) is a primary chromosome abnormality in basal cell carcinomas
Cancer Res, 57 (3), 404-6
PubMed 9012465
5-Aminolevulinic acid-based photodynamic therapy. Clinical research and future challenges
Cancer, 79 (12), 2282-308
DOI 10.1002/(sici)1097-0142(19970615)79:12<2282::aid-cncr2>3.0.co;2-o, PubMed 9191516
Publications 1996
Build-up of esterified aminolevulinic-acid-derivative-induced porphyrin fluorescence in normal mouse skin
J Photochem Photobiol B, 34 (1), 95-6
DOI 10.1016/1011-1344(95)07268-3, PubMed 8765664
Publications 1995
MEASUREMENTS OF SENSITIZER FLUORESCENCE IN PATIENTS BY MEANS OF AN ORDINARY FLUORESCENCE SPECTROMETER
P SOC PHOTO-OPT INS, 2371, 516-522
Distribution of 5-aminolevulinic acid-induced porphyrins in noduloulcerative basal cell carcinoma
Photochem Photobiol, 62 (5), 906-13
DOI 10.1111/j.1751-1097.1995.tb09154.x, PubMed 8570730
Photodynamic therapy of human malignant tumors: a study of epithelial tumors of the skin, gastrointestinal tract and malignant pleural mesothelioma
Department of Surgical Oncology, The Norwegian Radium Hospital, University of Oslo, [Oslo], 1 b. (flere pag.)
BIBSYS 952205750, ISBN 82-7722-038-3
PHOTODYNAMIC THERAPY OF MALIGNANT MESOTHELIOMA OF PLEURA
P SOC PHOTO-OPT INS, 2371, 166-170
PHOTODYNAMIC THERAPY WITH 5-AMINOLEVULINIC ACID INDUCED PORPHYRINS AND DMSO/EDTA FOR BASAL CELL CARCINOMA
P SOC PHOTO-OPT INS, 2371, 226-235
PHOTODYNAMIC THERAPY OF HUMAN TUBULO-VILLOUS ADENOMAS
P SOC PHOTO-OPT INS, 2325, 425-436
Publications 1994
Multiple glove powder granulomas masquerading as peritoneal carcinomatosis
J Am Coll Surg, 179 (3), 299-304
PubMed 8069426
DOSIMETRY AND LIGHT-DISTRIBUTION SYSTEMS FOR PHOTODYNAMIC THERAPY AT THE NORWEGIAN-RADIUM-HOSPITAL
P SOC PHOTO-OPT INS, 2078, 27-36
DOI 10.1117/12.168711
Publications 1992
Distribution and photosensitizing efficiency of porphyrins induced by application of exogenous 5-aminolevulinic acid in mice bearing mammary carcinoma
Int J Cancer, 52 (3), 433-43
DOI 10.1002/ijc.2910520318, PubMed 1399120
Publications 1986
[Drug-induced gastrointestinal hemorrhage. It is possible to reduce the occurrence?]
Tidsskr Nor Laegeforen, 106 (8), 662-6
PubMed 3486495